Anesthesia; Functional Completed Phase 4 Trials for Neostigmine (DB01400)

IndicationStatusPhase
DBCOND0051867 (Anesthesia; Functional)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02455921
Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in ChildrenScreening